The Effect of Immersive VR Distraction on Memory: Study 2

September 19, 2025 updated by: Hunter Hoffman, University of Washington

Immersive Virtual Reality Induces Procedural Analgesia, Anxiolysis and Anterograde Amnesia:A Randomized Controlled Study 2

This study measures how many words people can recall. Some words are studied/heard/learned while in immersive Virtual Reality, and some are studied/heard/learned while in a plausible control distraction.

Study Overview

Detailed Description

In this Study (n=20), participants recalled word lists during a plausible semi-immersive control condition (passive Apple Vision Pro see-through mode) versus during interactive immersive VR. Participants also later received brief heat pain stimuli during No VR versus immersive VR and provided pain and anxiety and distraction ratings on 0-10 graphic rating scales.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Washington
      • Seattle, Washington, United States, 98195
        • University of Washington

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Currently enrolled in a course at the University of Washington Psychology Dept., participating in the UW Psychology subject pool
  • Able to read, write and comprehend English
  • Able to complete study measures
  • Willing to follow our UW approved instructions
  • 18 years of age or older

Exclusion Criteria:

  • People who have already previously participated in this same study (e.g., last quarter) are not eligible to participate again.
  • Not enrolled in a course at the University of Washington Psychology Dept., not participating in the UW Psychology subject pool
  • Not be able to read, write and comprehend English
  • Younger than 18 years of age.
  • Not capable of completing measures
  • Not capable of indicating pain intensity,
  • Not capable of filling out study measures,
  • Extreme susceptibility to motion sickness,
  • Seizure history,
  • Unusual sensitivity or lack of sensitivity to pain,
  • Sensitive skin,
  • Sensitive feet
  • Migraines
  • Diabetes

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: High Tech virtual reality
Participants used their cyberhands to interact with virtual objects while in immersive virtual reality, while they listen to and memorize a list of 15 study words rea to them from the real world.
While wearing an immersive VR helmet, participants grabbed virtual objects andd put them into a bowl of virtual water, while memorizing a list of words from the real world.
Sham Comparator: Low Tech VR
Participants wore an Apple Vision Pro VR goggles that allowed them to see the real world in their VR goggles, via video streaming from cameras mounted on the VR helmet, while memorizing a list of words they heard from the real world.
Participant passively viewed the laboratory room they saw while wearing Apple Vision Pro goggles, while memorizing a list of words read to them from the real world.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Word Recall accuracy
Time Frame: begin 15 seconds after the last word
Number of study words recalled during an immediate recall task
begin 15 seconds after the last word
Subjective ratings of Distraction
Time Frame: Measured immediately after the free recall of each word list.
Participants rated how distracted they were in each treatment condition
Measured immediately after the free recall of each word list.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
During Phase 2, VR pain reduction was measured
Time Frame: subjective pain ratings measured immediately after each brief thermal stimulus
graphic ratings of worst pain intensity and other GRS pain ratings during brief thermal stimulation
subjective pain ratings measured immediately after each brief thermal stimulus

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: HUNTER HOFFMAN, PhD, University of Washington

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 31, 2024

Primary Completion (Actual)

February 11, 2025

Study Completion (Actual)

February 11, 2025

Study Registration Dates

First Submitted

September 10, 2025

First Submitted That Met QC Criteria

September 14, 2025

First Posted (Estimated)

September 19, 2025

Study Record Updates

Last Update Posted (Estimated)

September 24, 2025

Last Update Submitted That Met QC Criteria

September 19, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • VRAnalgesia2025b

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

De-identified summarized aggregated data will be available upon reasonable request.

IPD Sharing Time Frame

De-identified summarized aggregated data will be available upon publication in a peer reviewed journal until 2030

IPD Sharing Access Criteria

summarized aggregate data will be made available upon reasonable request by e-mailing the primary contact.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Virtual Reality Amnesia

Clinical Trials on Immersive Virtual Reality

Subscribe